Physical Activity Measurement Lab
Athens, Georgia, 30605, United States
Location status: Recruiting
NCT Number: NCT07520786
Time-restricted Eating (TRE) is a dietary approach that limits food intake to 4 - 12-hour windows without intentionally altering diet quality. TRE has several benefits including modest reductions in body weight and fat mass, improved glucose control, and reduced inflammatory markers. While research supports the metabolic and weight related benefits of TRE, there is limited evidence of its effects on physical activity (PA), sedentary behavior (SB) and sleep - the core components of 24-hour Activity Cycle (24-HAC), which is a holistic framework that integrates the three health-related activities. TRE research has largely focused on clinical populations, leaving its feasibility and adherence in healthy younger adults understudied. Within this group, college students' misaligned circadian rhythms and unpredictable schedules may make adherence to TRE challenging, highlighting the need for research on its practicality in this group. These outcomes are also particularly important to investigate in women, considering that SB is more prevalent among college-aged women (69%) compared to men (46%). To address these issues, we will conduct a three-week intervention to study the effects of TRE on the 24-HAC outcomes. College aged women will be screened and enrolled, then assigned to either a control or TRE group. Participants in the TRE group will self-select the timing of their 8-hour eating window which they will maintain throughout the study (with compliance on at least six days per week needed to be considered adherent). The control group will receive a basic nutrition education at the start of the study and will have no restriction on eating times. 24 HAC behaviors will be measured continuously for one-week of baseline measurement and throughout the intervention by wrist-worn ActiGraph GT9X monitors. Participants will also record the timing of their first and last meal each day and receive periodic reminders to report their hunger and satiety ratings using visual analog scales.
Interested in participating?
Request Info18 year–26 year
Female
Interventional
Not applicable
Athens, Georgia, 30605, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants randomized to the TRE group will self-select a consistent 8-hour daily eating window that aligns with their usual schedule. Participants will be instructed to consume all caloric intake within this 8-hour window and abstain from caloric intake outside of the window for 3 weeks.
Participants will be instructed not to intentionally modify diet quality or caloric intake during the intervention period, aside from restricting meal timing. Consumption of water and non-caloric beverages (e.g., black coffee, unsweetened tea) will be permitted outside the eating window to maintain hydration.
Other names: TRE
The control group in this study will receive a basic nutrition education. This group will follow normal eating patterns for 3 weeks.
Time frame: From enrollment to the end of study participation (4 weeks)
Physical activity (PA), sedentary behavior (SB) and sleep duration, the three main components of 24-Hour Activity Cycle will be measured using an ActiGraph GT9X (wrist watch style activity monitor) worn continuously on the non-dominant wrist during baseline and intervention weeks. ActiGraph accelerometers are widely used for measuring PA intensity and SB time, energy expenditure and sleep. Non-sedentary time will be used as a metric to measure time spent in PA. The Choi 90-minute algorithm will be used to identify ActiGraph non-wear times. Participants will report their sleep time and wake time in the Daily Survey. Total sleep time will be calculated as the difference in their self-reported sleep and wake times.
Time frame: From enrollment to the end of study participation (4 weeks)
ActiGraph sleep measures will be used to objectively estimate sleep quality. ActiGraphy has been previously used in TRE studies to track sleep quality. Sleep quality parameters from the ActiGraph include sleep latency, sleep efficiency and wake after sleep onset (WASO).
Time frame: At the beginnning of the study and at the end of study
For a subjective measure of sleep quality, Pittsburgh Sleep Quality Index (PSQI) will be used. PSQI is a self-report questionnaire that assesses multiple dimensions of sleep, including both subjective and objective parameters. PSQI has a total global score ranging from 0 to 21. A score of 0 indicates the best sleep quality, while 21 indicates the worst. A total score greater than 5 is generally considered to indicate poor sleep quality. It is a well validated and reliable measure of sleep quality over a one-month interval.
Time frame: Three times on one randomly day for 4 weeks
A Hunger and Fullness visual analogue scale will be used to assess hunger and appetite. Participants will self-administer this scale three times (wake time, midday, and bedtime) on a randomly chosen day each week.
Time frame: Once a week for 4 weeks
Mood states will be assessed using Positive and Negative Affect Schedule-Short Form (PANAS-SF), which will be administered three times (wake-time, midday, and sleep time) on a randomly selected day once a week. Scores for both Positive Affect (PA) and Negative Affect (NA) range from 10 to 50, with higher scores indicating higher levels of that emotional state
Contact information is provided by the study sponsor or research team.
University of Georgia
Other
DAWGS in Time-Restricted Eating and Activity Trends (DAWG-TREAT)
Acronym: DAWG-TREAT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06700525
Behavior, Dyssomnias
Tempe, Arizona, United States
View Trial DetailsNCT07140185
Behavior, Dyssomnias
Sfax, Tunisia
View Trial DetailsNCT07071324
Behavior, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Denver, Colorado, United States
View Trial DetailsNCT06002022
Behavior, Breast Cancer
Valencia, Spain
View Trial Details